市場調查報告書
商品編碼
921852
子宮鏡的全球市場:成長,趨勢,預測(2020年~2025年)Hysteroscope Market - Growth, Trends, and Forecasts (2022 - 2027) |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
子宮鏡,用於診斷出血和痙攣,妊娠相關異常。子宮鏡主要用於手術和診斷。美國國立癌症研究所的2016年的調查中,2006年每10萬人有24.1%的子宮癌發生率,2016年上升到27.6%。子宮癌的發生率上升,及微創診斷及微創治療設備的需求增加,技術進步等促進這個市場成長。
本報告提供全球子宮鏡市場調查,市場概要,各產品、用途、終端用戶、地區的市場規模的變化與預測,市場成長要素及阻礙因素分析,市場機會及未來趨勢,競爭情形,主要企業的簡介等全面性資訊。
A hysteroscope is used to assess the uterus for diagnosing abnormalities like heavy bleeding, severe cramping, frequent miscarriages, or problems related to conceiving. Hysteroscopes are used mainly for two purposes-operative and diagnostics.
According to National Cancer Institute, in 2017, there were an estimated 793,846 women living with uterine cancer in the United States. Increasing incidence uterine cancer, have been the primary driving factor for the growth of this market. Also, growing demand for minimally invasive diagnosis and treatment equipment and technological advancements in the development of new hysteroscope technologies have also helped the market grow.
However, lack of trained professionals and risk of infection due to equipment have been restraining the growth of this market.
Rigid operative hysteroscopes are the diagnosis and surgery equipment that require assembly. Rigid Hysteroscopes are more durable than flexible hysteroscopes. The use of rigid hysteroscopes has increased recently as they allow both diagnosis and treatment. Rigid hysteroscopes are used is treatment for various uterine abnormalities like removing polyps and fibroids and treating uterine cancer.
According to the National Cancer Institute, approximately 3.1 percent of women will be diagnosed with uterine cancer at some point during their lifetime, based on 2015-2017 data. As number of these dreadful illnesses increase, the demand for equipment for diagnosis and treatment will also increase. This factor is expected to increase the growth of Rigid Non-Video Hysteroscopes.
According to National Cancer Institute, uterine cancer represents 3.6% of all new cancer cases in the United States. Hence as the prevalence and mortality rate of Uterine cancer increase, the demand for equipment for diagnosis and treatment for such illnesses will increase
Moreover, the United States is a developed country and has a well structured healthcare system. As a result the expenditure on research and developmnet for equipment that are minimally invasive and more effective is also high. Hence, owing to these factors, the United Sates is expected to cover a large share of Hysteroscope Market.
Majority of the Hysteroscope are being manufactured by the global key players. Market leaders with more funds for research and better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness, which has helped the market grow.